70 related articles for article (PubMed ID: 3941713)
1. Low-dose cytarabine: persistence of a clonal abnormality during complete remission of acute nonlymphocytic leukemia.
Tilly H; Bastard C; Bizet M; Piguet H; Castaigne S; Degos L
N Engl J Med; 1986 Jan; 314(4):246-7. PubMed ID: 3941713
[No Abstract] [Full Text] [Related]
2. Therapy of secondary acute nonlymphocytic leukemia with cytarabine.
Preisler HD; Early AP; Raza A; Vlahides G; Marinello MJ; Stein AM; Browman G
N Engl J Med; 1983 Jan; 308(1):21-3. PubMed ID: 6847919
[No Abstract] [Full Text] [Related]
3. [Low-dose cytosine arabinoside (Ara-C) continuous infusion regimen for atypical nonlymphocytic leukemia--clinical study of the remission mechanism by serial chromosomal findings, colony formation and plasma Ara-C concentration].
Tagawa M; Tomonaga M; Shibata J; Nishino K; Nonaka H; Ikeda S; Suzuyama J; Amenomori T; Matuo T; Kuriyama K
Rinsho Ketsueki; 1984 Oct; 25(10):1606-17. PubMed ID: 6520937
[No Abstract] [Full Text] [Related]
4. [Effectiveness of low dose Ara-C in acute nonlymphocytic leukemia and myelodysplastic syndromes--analysis of factors influencing the duration of responses, survival and clinical effects].
Sawada H; Abe T; Akasaka K; Ishikura H; Izumi Y; Inamoto Y; Usui T; Okazaki T; Okada H; Katoh Y
Rinsho Ketsueki; 1987 Sep; 28(9):1553-60. PubMed ID: 3437517
[No Abstract] [Full Text] [Related]
5. Prolonged unmaintained remission after intensive consolidation therapy in adult acute nonlymphocytic leukemia.
Cassileth PA; Begg CB; Silber R; Spiers A; Burkart PT; Scharfman W; Knospe WH; Bennett JM; Mazza JJ; Oken MM
Cancer Treat Rep; 1987 Feb; 71(2):137-40. PubMed ID: 3802110
[TBL] [Abstract][Full Text] [Related]
6. [A therapeutic trial with low-dose Ara-C in acute nonlymphocytic leukemia and myelodysplastic syndromes: a study of 15 cases].
Maruta A; Miyashita H; Kodama F; Harano H; Kanamori H; Takahashi K; Noguchi T; Matsuzaki M; Ogawa K; Motomura S
Rinsho Ketsueki; 1988 Jan; 29(1):8-13. PubMed ID: 3385938
[No Abstract] [Full Text] [Related]
7. Clinical effect of low dose ara-C in twenty patients with acute nonlymphocytic leukemia, atypical leukemia, and refractory anemia with excess of blasts.
Izumi Y; Sawada H; Okazaki T; Mochizuki T; Ishikura H; Tashima M; Yamagishi M; Uchino H; Usui T; Akasaka S
Nihon Ketsueki Gakkai Zasshi; 1986 Feb; 49(1):93-100. PubMed ID: 3705895
[No Abstract] [Full Text] [Related]
8. Treatment of acute leukemia with amsacrine and high-dose cytarabine.
Arlin ZA; Gaddipati J; Ahmed T; Mittelman A; Friedland M; Rieber E
Cancer Treat Rep; 1985 Sep; 69(9):1001-2. PubMed ID: 3839713
[TBL] [Abstract][Full Text] [Related]
9. Treatment of refractory acute nonlymphocytic leukemia with a combination of pyrazofurin and cytarabine.
Kaplan HG; Appelbaum FR; Cheever MA; Greenberg PD; Wood T; Fefer A
Cancer Treat Rep; 1982 Jun; 66(6):1397-8. PubMed ID: 7083242
[TBL] [Abstract][Full Text] [Related]
10. [The clinical effect of low-dose Ara-C in patients with refractory acute nonlymphocytic leukemia and myelodysplastic syndrome].
Yoshida M; Tsunoda S; Akutsu M; Furukawa Y; Takeda K; Akashi M; Komatsu N; Muroi K; Ikeda K; Ohsaka A
Gan To Kagaku Ryoho; 1987 Apr; 14(4):1057-62. PubMed ID: 3566302
[TBL] [Abstract][Full Text] [Related]
11. Acute nonlymphocytic leukemia: expression in cells restricted to granulocytic and monocytic differentiation.
Fialkow PJ; Singer JW; Adamson JW; Berkow RL; Friedman JM; Jacobson RJ; Moohr JW
N Engl J Med; 1979 Jul; 301(1):1-5. PubMed ID: 286882
[TBL] [Abstract][Full Text] [Related]
12. Pediatric Oncology Group Study of in vitro clonal growth patterns of leukemic cells in childhood acute nonlymphocytic leukemia as a predictor of induction response.
Findley HW; Steuber CP; Krischer JP; Ragab AH
Cancer Res; 1987 Aug; 47(15):4225-8. PubMed ID: 3607762
[TBL] [Abstract][Full Text] [Related]
13. Chromosomal alterations in acute leukemia patients studied with improved culture methods.
Testa JR; Misawa S; Oguma N; Van Sloten K; Wiernik PH
Cancer Res; 1985 Jan; 45(1):430-4. PubMed ID: 3855285
[TBL] [Abstract][Full Text] [Related]
14. Chemotherapy sensitivity assessment of leukemic colony-forming cells with in vitro simultaneous exposure to multiple drugs: clinical correlations in acute nonlymphocytic leukemia.
Park CH; Amare M; Morrison FS; Maloney TR; Goodwin JW
Cancer Treat Rep; 1982 Jun; 66(6):1257-61. PubMed ID: 7083232
[TBL] [Abstract][Full Text] [Related]
15. Aclarubicin in the treatment of acute nonlymphocytic leukemia refractory to treatment with daunorubicin and cytarabine: a phase II trial.
Pedersen-Bjergaard J; Brincker H; Ellegaard J; Drivsholm A; Freund L; Jensen KB; Jensen MK; Nissen NI
Cancer Treat Rep; 1984 Oct; 68(10):1233-8. PubMed ID: 6597002
[TBL] [Abstract][Full Text] [Related]
16. Small-dose cytosine arabinoside in the treatment of elderly patients with acute leukemia and refractory anemia with excess of blast.
Satou Y; Kubota T; Yonekura S; Noguchi K; Oobayashi Y; Nagao T; Arimori S
Tokai J Exp Clin Med; 1986 Oct; 11(4):249-54. PubMed ID: 3617109
[TBL] [Abstract][Full Text] [Related]
17. High-dose cytosine arabinoside and daunorubicin as consolidation therapy for acute nonlymphocytic leukemia in first remission: an update.
Wolff SN; Herzig RH; Phillips GL; Lazarus HM; Greer JP; Stein RS; Ray WA; Herzig GP
Semin Oncol; 1987 Jun; 14(2 Suppl 1):12-7. PubMed ID: 3589687
[TBL] [Abstract][Full Text] [Related]
18. Remission-induction regimens in acute nonlymphocytic leukemia.
Brennan DC; Lewis JP
West J Med; 1980 Oct; 133(4):279-88. PubMed ID: 7347042
[TBL] [Abstract][Full Text] [Related]
19. [Intermediate- and high-dose cytosine arabinoside therapy in acute refractory leukemia].
Ohshima A; Yoshida K; Sato T; Miyazaki S; Yanagisawa M; Nakayama Y; Takahashi T; Mamiya S; Fukusima Y; Miura AB
Gan To Kagaku Ryoho; 1987 Jan; 14(1):192-5. PubMed ID: 3800405
[TBL] [Abstract][Full Text] [Related]
20. Cytarabine and thioguanine for acute nonlymphocytic leukemia. Another look.
Saponara EJ; Rothenberg SP; Villamena D
Arch Intern Med; 1979 Nov; 139(11):1277-80. PubMed ID: 292356
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
